The first import-substituting production of sterile medicinal products in the form of infusion solutions and injections in ampoules, which meets all the requirements of international GMP standards, was opened in Kyrgyzstan.
Support in the amount of $7.7 million was allocated for the implementation of the project.
The production capacity of the enterprise is 18 million vials and 5.7 million ampoule packages per year. This will fully meet the needs of the country’s healthcare system for infusion solutions, injections in ampoules and eye drops.
The plant representatives clarified that it produces sterile medicinal products in a fully automated production environment, which ensures the safety and quality of products at all stages.
